Critical Contrast: TerrAscend (TSNDF) vs. Its Competitors
by Doug Wharley · The Cerbat GemTerrAscend (OTCMKTS:TSNDF – Get Free Report) is one of 43 public companies in the “Agricultural production – crops” industry, but how does it compare to its peers? We will compare TerrAscend to similar companies based on the strength of its institutional ownership, profitability, valuation, dividends, analyst recommendations, earnings and risk.
Analyst Recommendations
This is a summary of current ratings for TerrAscend and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TerrAscend | 0 | 1 | 0 | 1 | 3.00 |
| TerrAscend Competitors | 320 | 262 | 606 | 34 | 2.29 |
As a group, “Agricultural production – crops” companies have a potential upside of 74.82%. Given TerrAscend’s peers higher possible upside, analysts plainly believe TerrAscend has less favorable growth aspects than its peers.
Profitability
This table compares TerrAscend and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TerrAscend | -23.95% | -31.48% | -11.40% |
| TerrAscend Competitors | -98.15% | -2,439.03% | -14.56% |
Risk and Volatility
TerrAscend has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, TerrAscend’s peers have a beta of -19.62, suggesting that their average share price is 2,062% less volatile than the S&P 500.
Insider and Institutional Ownership
5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares TerrAscend and its peers top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| TerrAscend | $317.33 million | -$95.54 million | -1.22 |
| TerrAscend Competitors | $1.23 billion | -$827,419.35 | 6.80 |
TerrAscend’s peers have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
TerrAscend beats its peers on 7 of the 13 factors compared.
TerrAscend Company Profile
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.